SCHEMBL32660979

SCHEMBL32660979

Clc1ccc(Nc2ccccc2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.47
FABP4 P15090 1/20 0.47
FABP5 Q01469 1/20 0.47
CYP1A2 P05177 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
PLA2G1B P04054 1/20 0.44
THRB P10828 1/20 0.44
NPY1R P25929 1/20 0.44
NPY2R P49146 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
PDE5A O76074 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
DHODH Q02127 1/20 0.44
CYP2A6 P11509 1/20 0.43
MAPK13 O15264 1/20 0.43
MAPK12 P53778 1/20 0.43
MAPK11 Q15759 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24947167 0.88 CYP1A2 (0.56) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL29791637 0.87 CYP1A2 (0.42) CYP1A2SMN1; SMN2LMNAPLA2G1BTHRB
SCHEMBL29013448 0.86 MAPT (0.50) SMN1; SMN2LMNAL3MBTL1DHODHTP53
SCHEMBL15549870 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL24057710 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL5365481 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL4428807 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL23111305 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL5457659 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2
SCHEMBL17733473 0.86 FABP3 (0.52) FABP3FABP4FABP5CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260020493-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2026-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260020493-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SOD1, GPS1, MT-CO1 FABP3 4855/4885FABP4 4883/4885FABP5 4869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.